CI_with has_Ingredient has_MoA has_PE may_treat drug associated with AE in adult used to treat disease Topoisomerase Inhibitors [MoA] Breast Neoplasms [Disease/Finding] Drug Hypersensitivity [Disease/Finding] Heart Failure [Disease/Finding] Lymphoma [Disease/Finding] Multiple Sclerosis [Disease/Finding] Pain [Disease/Finding] Prostatic Neoplasms [Disease/Finding] Sarcoma [Disease/Finding] Leukemia, Myeloid, Acute [Disease/Finding] Decreased DNA Integrity [PE] Decreased RNA Integrity [PE] Pregnancy [Disease/Finding] MITOXANTRONE HYDROCHLORIDE http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4d0f0f1a-31af-40fa-9c64-e90891fa6ce4#nlm34084-4 U6USW86RD0 <VANDF_Record>50.416^2142^</VANDF_Record><VA_File>50.416</VA_File><VA_IEN>2142</VA_IEN> Ingredient C0700458 203129 4019527 MITOXANTRONE HYDROCHLORIDE C17378 Mitoxantrone Hydrochloride Active N0000147641 MITOXANTRONE Mitoxantrone Hydrochloride [Chemical/Ingredient] secondary progressive multiple sclerosis prostate cancer acute myeloid leukemia fatigue AE fungal infection AE amenorrhoea AE dyspnea AE upper respiratory tract infection AE fever AE infection AE headache AE anorexia AE cough AE abdominal pain AE back pain AE alopecia AE hemorrhage AE urine abnormality AE urinary tract infection AE edema AE sinusitis AE seizure AE nausea AE vomiting AE constipation AE stomatitis AE mouth mucosal ulceration AE diarrhea AE sepsis AE arrhythmia AE onycholysis AE petechiae AE renal failure AE heartburn AE menstrual disorder AE stomach pain AE